Skip to Main Content

Paper Details

Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
Nature
178
2020
5-azacytidine, CCR2, CXCR2, Cancer, DNA methyltransferase, MDSC, MDSCs, Myeloid cells, cancer, disseminating tumour cells, entinostat, histone deacetylase, lung metastases, lung, breast and oesophageal cancers, macrophage-like phenotype, myeloid-derived suppressor cells, premetastatic, primary tumours, residual tumour cells, tumour
Author NameAffiliation
Chi-Ping DayNational Cancer Institute, National Institutes of Health
Chi-Ping DayNational Cancer Institute, National Institutes of Health
Charles M RudinMemorial Sloan Kettering Cancer Center
Joseph B MargolickJohns Hopkins Bloomberg School of Public Health
Stephen B BaylinThe Johns Hopkins School of Medicine, The Sidney Kimmel Comprehensive Cancer Center
Stephen B BaylinThe Johns Hopkins School of Medicine, The Sidney Kimmel Comprehensive Cancer Center
  • 1 - 6

Datasets

Release 1.2